Ngā hua rapu - Gradl, Gabriele

Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons mā Gradl, Gabriele, Krieg, Eva-Maria, Schulz, Martin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016 mā Gradl, Gabriele, Teichert, Martina, Kieble, Marita, Werning, Johanna, Schulz, Martin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019 mā Gradl, Gabriele, Werning, Johanna, Enners, Salka, Kieble, Marita, Schulz, Martin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave mā Enners, Salka, Gradl, Gabriele, Kieble, Marita, Böhm, Michael, Laufs, Ulrich, Schulz, Martin

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion mā Rüsenberg, Robin, Baumgarten, Axel, Mauss, Stefan, Gradl, Gabriele, Schulz, Martin, Bartmeyer, Barbara, Kollan, Christian, Schmidt, Daniel

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany mā Moorkens, Evelien, Barcina Lacosta, Teresa, Vulto, Arnold G., Schulz, Martin, Gradl, Gabriele, Enners, Salka, Selke, Gisbert, Huys, Isabelle, Simoens, Steven

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa